The latest closing stock price for Ovid Therapeutics as of February 21, 2025 is 0.62.
An investor who bought $1,000 worth of Ovid Therapeutics stock at the IPO in 2017 would have $-950 today, roughly -1 times their original investment - a -31.16% compound annual growth rate over 8 years.
The all-time high Ovid Therapeutics stock closing price was 15.00 on May 19, 2017.
The Ovid Therapeutics 52-week high stock price is 3.79, which is 511.3% above the current share price.
The Ovid Therapeutics 52-week low stock price is 0.56, which is 9.7% below the current share price.
The average Ovid Therapeutics stock price for the last 52 weeks is 1.66.
An investor who bought $1,000 worth of Ovid Therapeutics stock at the IPO in 2017 would have $-950 today, roughly -1 times their original investment - a -31.16% compound annual growth rate over 8 years.
The all-time high Ovid Therapeutics stock closing price was 15.00 on May 19, 2017.
The Ovid Therapeutics 52-week high stock price is 3.79, which is 511.3% above the current share price.
The Ovid Therapeutics 52-week low stock price is 0.56, which is 9.7% below the current share price.
The average Ovid Therapeutics stock price for the last 52 weeks is 1.66.